This publication summarises medicines that were in use or being investigated to treat COVID-19 as at 7 October 2020. This publication remains available for reference but the information has not been updated since October 2020. The Commission acknowledges the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists for their contribution to this work.
For current resources, the National COVID-19 Clinical Evidence Taskforce has been established to provide evidence-based recommendations to guide care for people with COVID-19. The Taskforce undertakes detailed analyses of medicines for use in the treatment of COVID-19 which are updated as new research becomes available. The reviews are accompanied by therapy recommendations established through a consultation process.
Last updated 7 October 2020